title: [Recommendations for the definition of a policy on vaccination against papillomavirus in Mexico. Strategic Advisory Group of Experts of the World Health Organization].
authors: Instituto Nacional de Salud Pública, México. elazcano@insp.mx
authors: Eduardo
authors: E
authors: Lazcano-Ponce
authors: Jorge
authors: J
authors: Salmerón-Castro
authors: Alejandro
authors: A
authors: García-Carrancá
authors: Carlos
authors: C
authors: Aranda-Flores
authors: Vicente
authors: V
authors: Madrid-Marina
authors: César Misael
authors: CM
authors: Gómez-Altamirano
authors: Olga Georgina
authors: OG
authors: Martínez-Montañez
mesh_terms: D000293:Adolescent; D000328:Adult; D052685:Alphapapillomavirus / Q000276:immunology / Q000472:pathogenicity; D002648:Child; D003906:Developing Countries; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D006291:Health Policy; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D007115:Immunization Schedule; D008800:Mexico; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D053918:Papillomavirus Vaccines / Q000008:administration & dosage / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D014611:Vaccination / Q000331:legislation & jurisprudence; D055815:Young Adult
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines; C510352:human papillomavirus vaccine, L1 type 16, 18